CD8A and lung adenocarcinoma: Similarly, studies from Afroj et al. demonstrated that fibrocytes derived from PBMCs of patients with lung adenocarcinoma or murine MC38 tumors augmented the proliferation of CD8+ T cells with PD-L1 blockade, suggesting the role of fibrocytes in antitumor immunity39.